
For the past 40 years, cardiovascular disease and zzso zzso have been the leading causes of death in the zzso As treatments for cancer, cardiovascular disease, diabetes and other chronic illnesses improve, we are seeing more complicated patients in our zzso Cancer therapies such as zzso and radiation therapy continue to pose a risk for zzso cardiovascular disease, in spite of decades of zzso It has been reported that the risk of zzso heart failure is the second most common, late, long-term disabling health condition among cancer zzso zzso understanding of an zzso risk for cardiovascular complications of these therapies and earlier intervention for selected patients may help to improve the overall outcome for patients requiring these zzso New therapies targeting zzso and the process of zzso have zzso effects regarding the cardiovascular system that remain poorly zzso Our knowledge and experience in the cardiovascular care of patients with cancer must continue to grow if we are to assure the best possible outcome for these zzso The aim of this review is to highlight the risk of zzso zzso among several of the most commonly used cancer therapies, various ways to screen for patients at highest risk of zzso and management of cardiac complications of cancer zzso We spend a disproportionate amount of space and time on the subject of zzso toxicity due to its often devastating nature, and its persistence as a clinical problem despite decades of use and zzso 

